Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters

A human gut microbial gene catalogue established by metagenomic sequencing

MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · see citing works

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969 · see citing works

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549 · see citing works

The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T _reg Cell Homeostasis

Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413 · see citing works

Role of the microbiota in immunity and inflammation.

Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385 · see citing works

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation

Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838 · see citing works

Richness of human gut microbiome correlates with metabolic markers

Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662 · see citing works

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · see citing works

<i>Faecalibacterium prausnitzii</i> is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · see citing works

Induction of Colonic Regulatory T Cells by Indigenous <i>Clostridium</i> Species

Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752 · see citing works

Gut microbiota composition correlates with diet and health in the elderly

Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314 · see citing works

Gut metagenome in European women with normal, impaired and diabetic glucose control

Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · see citing works

Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872 · see citing works

UniFrac: an effective distance metric for microbial community comparison

Lozupone, C., Lladser, M. E., Knights, D., Stombaugh, J., & Knight, R. (2011) · The ISME Journal · doi:10.1038/ismej.2010.133 · Cited by 2,825 · see citing works

The effect of infections on susceptibility to autoimmune and allergic diseases.

Bach, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,714 · see citing works

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697 · see citing works

Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach

Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277 · see citing works

Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis

Scher, J. U., Sczesnak, A., Longman, R. S., Segata, N., Ubeda, C., Bielski, C., Rostron, T., Cerundolo, V., Pamer, E. G., Abramson, S. B., et al. (2013) · eLife · doi:10.7554/elife.01202 · Cited by 2,047 · see citing works

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis

Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000082107 · Cited by 1,323 · see citing works

Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease

Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Fölsch, U. R., Timmis, K. N., & Schreiber, S. (2004) · Gut · doi:10.1136/gut.2003.025403 · Cited by 1,311 · see citing works

Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination

Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G. (2011) · Nature · doi:10.1038/nature10554 · Cited by 1,251 · see citing works

Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives

Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S. (2011) · Gut · doi:10.1136/gut.2010.223263 · Cited by 1,063 · see citing works

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21141 · Cited by 714 · see citing works

Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases

Peterson, D. A., Frank, D. N., Pace, N. R., & Gordon, J. I. (2008) · Cell Host &amp; Microbe · doi:10.1016/j.chom.2008.05.001 · Cited by 503 · see citing works

Dysbiosis of Salivary Microbiota in Inflammatory Bowel Disease and Its Association With Oral Immunological Biomarkers

Said, H. S., Suda, W., Nakagome, S., Chinen, H., Oshima, K., Kim, S., Kimura, R., Iraha, A., Ishida, H., Fujita, J., et al. (2013) · DNA Research · doi:10.1093/dnares/dst037 · Cited by 394 · see citing works

Application of Novel PCR-Based Methods for Detection, Quantitation, and Phylogenetic Characterization of <i>Sutterella</i> Species in Intestinal Biopsy Samples from Children with Autism and Gastrointestinal Disturbances

Williams, B. L., Hornig, M., Parekh, T., & Lipkin, W. I. (2012) · mBio · doi:10.1128/mbio.00261-11 · Cited by 378 · see citing works

Central Nervous System Demyelinating Disease Protection by the Human Commensal <i>Bacteroides fragilis</i> Depends on Polysaccharide A Expression

Ochoa-Repáraz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Begum-Haque, S., Dasgupta, S., Kasper, D. L., & Kasper, L. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001443 · Cited by 367 · see citing works

Robustness of Gut Microbiota of Healthy Adults in Response to Probiotic Intervention Revealed by High-Throughput Pyrosequencing

Kim, S.-W., Suda, W., Kim, S., Oshima, K., Fukuda, S., Ohno, H., Morita, H., & Hattori, M. (2013) · DNA Research · doi:10.1093/dnares/dst006 · Cited by 338 · see citing works

Highlighting new phylogenetic specificities of Crohn's disease microbiota

Mondot, S., Kang, S., Furet, J., de Cárcer, D. A., McSweeney, C., Morrison, M., Marteau, P., Doré, J., & Leclerc, M. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21436 · Cited by 283 · see citing works

NKT Cell-Dependent Amelioration of a Mouse Model of Multiple Sclerosis by Altering Gut Flora

Yokote, H., Miyake, S., Croxford, J. L., Oki, S., Mizusawa, H., & Yamamura, T. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080622 · Cited by 264 · see citing works

Geographical patterns of the standing and active human gut microbiome in health and IBD

Rehman, A., Rausch, P., Wang, J., Skiecevičienė, J., Kiudelis, G., Bhagalia, K., Amarapurkar, D. N., Kupčinskas, L., Schreiber, S., Rosenstiel, P. C., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308341 · Cited by 179 · see citing works

The heterotaxy gene GALNT11 glycosylates Notch to orchestrate cilia type and laterality

Boskovski, M. T., Yuan, S., Borbye‐Lorenzen, N., Goth, C. K., Makova, S. Z., Clausen, H., Brueckner, M. K., & Khokha, M. K. (2013) · Nature · doi:10.1038/nature12723 · Cited by 171 · see citing works

Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years

Osoegawa, M., Kira, J., Fukazawa, T., Fujihara, K., Kikuchi, S., Matsui, M., Kohriyama, T., Sobue, G., Yamamura, T., Itoyama, Y., et al. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508098372 · Cited by 162 · see citing works

Bacterial Lipodipeptide, Lipid 654, Is a Microbiome-Associated Biomarker for Multiple Sclerosis

Farrokhi, V., Nemati, R., Nichols, F. C., Yao, X., Anstadt, E., Fujiwara, M., Grady, J., Wakefield, D., Castro, W., Donaldson, J., et al. (2013) · Clinical &amp; Translational Immunology · doi:10.1038/cti.2013.11 · Cited by 109 · see citing works

Characterization of Adherent Bacteroidales from Intestinal Biopsies of Children and Young Adults with Inflammatory Bowel Disease

Zitomersky, N. L., Atkinson, B. J., Franklin, S. W., Mitchell, P. D., Snapper, S. B., Comstock, L. E., & Bousvaros, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063686 · Cited by 107 · see citing works

Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan

Houzen, H., Niino, M., Hirotani, M., Fukazawa, T., Kikuchi, S., Tanaka, K., & Sasaki, H. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.08.032 · Cited by 103 · see citing works

A Comprehensive Evaluation of Colonic Mucosal Isolates of Sutterella wadsworthensis from Inflammatory Bowel Disease

Mukhopadhya, I., Hansen, R., Nicholl, C. E., Alhaidan, Y., Thomson, J., Berry, S., Pattinson, C., Stead, D., Russell, R., El-Omar, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027076 · Cited by 87 · see citing works

Serine Lipids of Porphyromonas gingivalis Are Human and Mouse Toll-Like Receptor 2 Ligands

Clark, R. B., Cervantes, J., Maciejewski, M. W., Farrokhi, V., Nemati, R., Yao, X., Anstadt, E. J., Fujiwara, M., Wright, K., Riddle, C., et al. (2013) · Infection and Immunity · doi:10.1128/iai.00803-13 · Cited by 86 · see citing works

Diet, Gut Flora, and Multiple Sclerosis: Current Research and Future Perspectives

Yamamura, T., & Miyake, S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7953-6_6 · Cited by 15 · see citing works

Multiple Sclerosis Immunology

Yamamura, T., Takashi, & Gran, B. (2013) · Springer: New York · doi:10.1007/978-1-4614-7953-6 · Cited by 7 · see citing works

The status of the name Lactobacillus rogosae Holdeman and Moore 1974. Opinion 88.Judicial Commission of the International Committee on Systematics of Prokaryotes

Tindall, B. J. (2014) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijs.0.069146-0 · Cited by 6 · see citing works

Interactions between the microbiota, immune and nervous systems in health and disease

Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017) · Nature Neuroscience · doi:10.1038/nn.4476 · Cited by 1,900 · see citing works

SCFA: mechanisms and functional importance in the gut

Martin‐Gallausiaux, C., Marinelli, L., Blottière, H. M., Larraufie, P., & Lapaque, N. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120006916 · Cited by 1,533 · see citing works

The gut microbiome in neurological disorders

Cryan, J. F., O'Riordan, K. J., Sandhu, K., Peterson, V., & Dinan, T. G. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30356-4 · Cited by 1,336 · see citing works

Alterations of the human gut microbiome in multiple sclerosis

Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12015 · Cited by 1,307 · see citing works

Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models

Cekanaviciute, E., Yoo, B. B., Runia, T. F., Debelius, J. W., Singh, S., Nelson, C., Kanner, R., Bencosme, Y., Lee, Y. K., Hauser, S. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711235114 · Cited by 1,040 · see citing works

Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice

Berer, K., Gerdes, L. A., Cekanaviciute, E., Jia, X., Xiao, L., Xia, Z., Liu, C., Klotz, L., Stauffer, U., Baranzini, S. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711233114 · Cited by 933 · see citing works

Multiple Sclerosis: Mechanisms and Immunotherapy

Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938 · see citing works

The Gut Microbiota and Alzheimer’s Disease

Jiang, C., Li, G., Huang, P., Liu, Z., & Zhao, B. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161141 · Cited by 852 · see citing works

The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology

Rutsch, A., Kantsjö, J. B., & Ronchi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604179 · Cited by 821 · see citing works

Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients

Bedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017) · Genome Medicine · doi:10.1186/s13073-017-0428-y · Cited by 642 · see citing works

Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota

Cignarella, F., Cantoni, C., Ghezzi, L., Salter, A., Dorsett, Y., Chen, L., Phillips, D., Weinstock, G. M., Fontana, L., Cross, A. H., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.006 · Cited by 568 · see citing works

Development and maintenance of intestinal regulatory T cells

Tanoue, T., Atarashi, K., & Honda, K. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.36 · Cited by 553 · see citing works

The pathogenicity of Th17 cells in autoimmune diseases

Yasuda, K., Takeuchi, Y., & Hirota, K. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00733-8 · Cited by 560 · see citing works

The gut microbiome in human neurological disease: A review

Tremlett, H., Bauer, K. C., Appel‐Cresswell, S., Finlay, B. B., & Waubant, E. (2017) · Annals of Neurology · doi:10.1002/ana.24901 · Cited by 535 · see citing works

The microbiome in autoimmune diseases

De Luca, F., & Shoenfeld, Y. (2018) · Clinical and Experimental Immunology · doi:10.1111/cei.13158 · Cited by 510 · see citing works

The hygiene hypothesis in autoimmunity: the role of pathogens and commensals

Bach, J. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.111 · Cited by 508 · see citing works

Microbiome–microglia connections via the gut–brain axis

Abdel-Haq, R., Schlachetzki, J. C. M., Glass, C. K., & Mazmanian, S. K. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180794 · Cited by 471 · see citing works

A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist?

Forbes, J. D., Chen, C., Knox, N., Marrie, R. A., El-Gabalawy, H. S., de Kievit, T. R., Alfa, M. J., Bernstein, C. N., & Domselaar, G. V. (2018) · Microbiome · doi:10.1186/s40168-018-0603-4 · Cited by 448 · see citing works

Fecal Microbiota Transplantation in Neurological Disorders

Vendrik, K. E. W., Ooijevaar, R. E., de Jong, P. R. C., Laman, J. D., van Oosten, B. W., van Hilten, J. J., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., & Contarino, M. F. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00098 · Cited by 413 · see citing works

Alterations in the gut microbiota can elicit hypertension in rats

Adnan, S., Nelson, J. W., Ajami, N. J., Venna, V. R., Petrosino, J. F., Bryan, R. M., & Durgan, D. J. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00081.2016 · Cited by 380 · see citing works

The impact of the gut microbiome on extra-intestinal autoimmune diseases

Miyauchi, E., Shimokawa, C., Steimle, A., Desai, M. S., & Ohno, H. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00727-y · Cited by 375 · see citing works

Gut microbiota in early pediatric multiple sclerosis: a case−control study

Tremlett, H. L., Fadrosh, D. W., Faruqi, A. A., Zhu, F., Hart, J., Roalstad, S., Graves, J., Lynch, S. V., & Waubant, E. L. (2016) · European Journal of Neurology · doi:10.1111/ene.13026 · Cited by 347 · see citing works

High frequency of intestinal T _H 17 cells correlates with microbiota alterations and disease activity in multiple sclerosis

Cosorich, I., Dalla-Costa, G., Sorini, C., Ferrarese, R., Messina, M. J., Dolpady, J., Radice, E., Mariani, A., Testoni, P. A., Canducci, F., et al. (2017) · Science Advances · doi:10.1126/sciadv.1700492 · Cited by 338 · see citing works

Connecting the immune system, systemic chronic inflammation and the gut microbiome: the role of sex

Rizzetto, L., Fava, F., Tuohy, K. M., & Selmi, C. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.05.008 · Cited by 331 · see citing works

The mutual interplay of gut microbiota, diet and human disease

Illiano, P., Brambilla, R., & Parolini, C. (2020) · FEBS Journal · doi:10.1111/febs.15217 · Cited by 331 · see citing works

Intestinal dysbiosis and probiotic applications in autoimmune diseases

de Oliveira, G. L. V., Leite, A. Z., Higuchi, B. S., Gonzaga, M. I., & Mariano, V. S. (2017) · Immunology · doi:10.1111/imm.12765 · Cited by 320 · see citing works

Gut microbiota in neurodegenerative disorders

Sarkar, S. R., & Banerjee, S. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.01.004 · Cited by 319 · see citing works

Smoking and microbiome in oral, airway, gut and some systemic diseases

Huang, C., & Shi, G. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1971-7 · Cited by 319 · see citing works

Gut Microbiota Regulation of T Cells During Inflammation and Autoimmunity

Brown, E., Kenny, D. J., & Xavier, R. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041841 · Cited by 310 · see citing works

Microglia, Lifestyle Stress, and Neurodegeneration

Madore, C., Yin, Z., Leibowitz, J. A., & Butovsky, O. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.003 · Cited by 310 · see citing works

Changes of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases

Gerhardt, S., & Mohajeri, M. H. (2018) · Nutrients · doi:10.3390/nu10060708 · Cited by 298 · see citing works

Recent developments in understanding the role of the gut microbiota in brain health and disease

Sherwin, E., Dinan, T. G., & Cryan, J. F. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13416 · Cited by 338 · see citing works

Gut Microbiome in Progressive Multiple Sclerosis

Cox, L. M., Maghzi, A. H., Liu, S., Tankou, S. K., Dhang, F. H., Willocq, V., Song, A., Wasén, C., Tauhid, S., Chu, R., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26084 · Cited by 292 · see citing works

Faecal microbiota transplant from aged donor mice affects spatial learning and memory via modulating hippocampal synaptic plasticity- and neurotransmission-related proteins in young recipients

D’Amato, A., Di Cesare Mannelli, L., Lucarini, E., Man, A. L., Le Gall, G., Branca, J. J. V., Ghelardini, C., Amedei, A., Bertelli, E., Regoli, M., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00914-w · Cited by 269 · see citing works

Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?

Pellegrini, C., Antonioli, L., Colucci, R., Blandizzi, C., & Fornai, M. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1856-5 · Cited by 270 · see citing works

Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease

Mangalam, A., Shahi, S. K., Luckey, D., Karau, M., Marietta, E., Luo, N., Choung, R. S., Ju, J., Sompallae, R., Gibson-Corley, K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.031 · Cited by 266 · see citing works

Gut microorganisms act together to exacerbate inflammation in spinal cords

Miyauchi, E., Kim, S.-W., Suda, W., Kawasumi, M., Onawa, S., Taguchi-Atarashi, N., Morita, H., Taylor, T. D., Hattori, M., & Ohno, H. (2020) · Nature · doi:10.1038/s41586-020-2634-9 · Cited by 268 · see citing works

Microbiota in the Gastrointestinal Tract

Dieterich, W., Schink, M., & Zopf, Y. (2018) · Medical Sciences · doi:10.3390/medsci6040116 · Cited by 269 · see citing works

A probiotic modulates the microbiome and immunity in multiple sclerosis

Tankou, S. K., Regev, K., Healy, B. C., Tjon, E. C., Laghi, L., Cox, L. M., Kivisäkk, P., Pierre, I. V., Hrishikesh, L., Gandhi, R., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25244 · Cited by 263 · see citing works

Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid

Yuille, S., Reichardt, N., Panda, S., Dunbar, H., & Mulder, I. E. (2018) · PLOS ONE · doi:10.1371/journal.pone.0201073 · Cited by 257 · see citing works

Phloretin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the gut microbiota.

Wu, M.-N., Li, P.-Z., An, Y., Ren, J., Yan, D., Cui, J., Li, D., Li, M., Wang, M.-Y., & Zhong, G.-S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104489 · Cited by 230 · see citing works

Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity

Yamamoto, E. A., & Jørgensen, T. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03141 · Cited by 265 · see citing works

Impacts of microbiome metabolites on immune regulation and autoimmunity

Haase, S., Haghikia, A., Wilck, N., Müller, D. N., & Linker, R. A. (2018) · Immunology · doi:10.1111/imm.12933 · Cited by 239 · see citing works

Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders

Mitrea, L., Nemeș, S. A., Szabo, K., Teleky, B., & Vodnar, D. C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.813204 · Cited by 242 · see citing works

Butyrate suppresses demyelination and enhances remyelination

Chen, T., Noto, D., Hoshino, Y., Mizuno, M., & Miyake, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1552-y · Cited by 229 · see citing works

The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models

Mizuno, M., Noto, D., Kaga, N., Chiba, A., & Miyake, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173032 · Cited by 230 · see citing works

The critical role of Faecalibacterium prausnitzii in human health: An overview

Leylabadlo, H. E., Ghotaslou, R., Feizabadi, M. M., Farajnia, S., Moaddab, S. Y., Ganbarov, K., Khodadadi, E., Tanomand, A., Sheykhsaran, E., Yousefi, B., et al. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104344 · Cited by 239 · see citing works

The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials

Duan, H., Wang, L., Huangfu, M., & Li, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115276 · Cited by 241 · see citing works

Gut microbiota–specific IgA + B cells traffic to the CNS in active multiple sclerosis

Pröbstel, A., Zhou, X., Baumann, R., Wischnewski, S., Kutza, M., Rojas, O. L., Sellrie, K., Bischof, A., Kim, K., Ramesh, A., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc7191 · Cited by 226 · see citing works

Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis

Kimura, K., Hohjoh, H., Fukuoka, M., Sato, W., Oki, S., Tomi, C., Yamaguchi, H., Kondo, T., Takahashi, R., & Yamamura, T. (2017) · Nature Communications · doi:10.1038/s41467-017-02406-2 · Cited by 222 · see citing works

Gut microbiome in multiple sclerosis: The players involved and the roles they play

Shahi, S. K., Freedman, S. N., & Mangalam, A. K. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1349041 · Cited by 218 · see citing works

Role of Gut Microbiota in Rheumatoid Arthritis

Maeda, Y., & Takeda, K. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6060060 · Cited by 217 · see citing works

Aging, Frailty, and the Microbiome—How Dysbiosis Influences Human Aging and Disease

Haran, J. P., & McCormick, B. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.09.060 · Cited by 220 · see citing works

Microbiota Signaling Pathways that Influence Neurologic Disease

Cox, L. M., & Weiner, H. L. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0598-8 · Cited by 208 · see citing works

Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle

Chidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204 · see citing works

The role of the gut microbiota in multiple sclerosis

Correale, J., Hohlfeld, R., & Baranzini, S. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00697-8 · Cited by 207 · see citing works

Lactobacillus reuteri tryptophan metabolism promotes host susceptibility to CNS autoimmunity

Montgomery, T. L., Eckstrom, K. M., Lile, K. H., Caldwell, S. K., Heney, E. R., Lahue, K. G., D’Alessandro, A., Wargo, M. J., & Krementsov, D. N. (2022) · Microbiome · doi:10.1186/s40168-022-01408-7 · Cited by 200 · see citing works

Rapid improvement in Alzheimer’s disease symptoms following fecal microbiota transplantation: a case report

Hazan, S. (2020) · Journal of International Medical Research · doi:10.1177/0300060520925930 · Cited by 200 · see citing works

Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis

Saresella, M., Marventano, I., Barone, M., Rosa, F. L., Piancone, F., Mendozzi, L., d’Arma, A., Rossi, V., Pugnetti, L., Roda, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01390 · Cited by 201 · see citing works

Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation

Park, J., Wang, Q., Wu, Q., Mao‐Draayer, Y., & Kim, C. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-45311-y · Cited by 197 · see citing works

Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic Diet

Swidsinski, A., Dörffel, Y., Loening-Baucke, V., Gille, C., Göktas, Ö., Reißhauer, A., Neuhaus, J., Weylandt, K.-H., Guschin, A., & Bock, M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01141 · Cited by 196 · see citing works

Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis

Takewaki, D., Suda, W., Sato, W., Takayasu, L., Kumar, N., Kimura, K., Kaga, N., Mizuno, T., Miyake, S., Hattori, M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011703117 · Cited by 188 · see citing works

The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials

Schepici, G., Silvestro, S., Bramanti, P., & Mazzon, E. (2019) · Cell Transplantation · doi:10.1177/0963689719873890 · Cited by 187 · see citing works

The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics

Camara-Lemarroy, C. R., Metz, L. M., Meddings, J. B., Sharkey, K. A., & Yong, V. W. (2018) · Brain · doi:10.1093/brain/awy131 · Cited by 188 · see citing works

The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis

Freedman, S. N., Shahi, S. K., & Mangalam, A. K. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0588-x · Cited by 168 · see citing works

The interplay between host immune cells and gut microbiota in chronic inflammatory diseases

Kim, D.-H., Zeng, M. Y., & Núñez, G. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.24 · Cited by 184 · see citing works

Intestinal Microbiota Influences Non-intestinal Related Autoimmune Diseases

Opazo, M. C., Ortega-Rocha, E. M., Coronado-Arrázola, I., Bonifaz, L. C., Boudin, H., Neunlist, M., Bueno, S. M., Kalergis, A. M., & Riedel, C. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00432 · Cited by 179 · see citing works

Microbiota-gut brain axis involvement in neuropsychiatric disorders

Iannone, L. F., Preda, A., Blottière, H. M., Clarke, G., Albani, D., Belcastro, V., Carotenuto, M., Cattaneo, A., Citraro, R., Ferraris, C., et al. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1638763 · Cited by 177 · see citing works

Gut microbiota composition and relapse risk in pediatric MS: A pilot study

Tremlett, H. L., Fadrosh, D. W., Faruqi, A. A., Hart, J., Roalstad, S., Graves, J. S., Lynch, S. V., Waubant, E. L., Aaen, G. S., Belman, A. L., et al. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.02.042 · Cited by 175 · see citing works

The Role of Diet in Multiple Sclerosis: Mechanistic Connections and Current Evidence

Sand, I. K. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0236-z · Cited by 178 · see citing works

Fatty acid metabolism in the progression and resolution of CNS disorders

Bogie, J. F. J., Haidar, M., Kooij, G., & Hendriks, J. J. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.01.004 · Cited by 167 · see citing works

The Impact of Gut Microbiota Disorders on the Blood–Brain Barrier

Wei, T., Zhu, H., Feng, Y., Guo, R., & Wan, D. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s254403 · Cited by 163 · see citing works

Dysbiosis of Gut Microbiota from the Perspective of the Gut–Brain Axis: Role in the Provocation of Neurological Disorders

Kandpal, M., Indari, O., Baral, B., Jakhmola, S., Tiwari, D., Bhandari, V., Pandey, R. K., Bala, K., Sonawane, A., & Jha, H. C. (2022) · Metabolites · doi:10.3390/metabo12111064 · Cited by 172 · see citing works

Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study

Saresella, M., Mendozzi, L., Rossi, V., Mazzali, F., Piancone, F., LaRosa, F., Marventano, I., Caputo, D., Felis, G. E., & Clerici, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01391 · Cited by 159 · see citing works

Current and Future Biomarkers in Multiple Sclerosis

Yang, J., Hamade, M., Wu, Q., Wang, Q., Axtell, R. C., Giri, S., & Mao‐Draayer, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115877 · Cited by 179 · see citing works

Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives

Chu, F., Shi, M., Lang, Y., Shen, D., Jin, T., Zhu, J., & Cui, L. (2018) · Mediators of Inflammation · doi:10.1155/2018/8168717 · Cited by 159 · see citing works

Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis

Zeng, Q., Gong, J., Liu, X., Chen, C., Sun, X., Li, H., Zhou, Y., Cui, C., Wang, Y., Yang, Y., et al. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104468 · Cited by 156 · see citing works

Investigation of probiotics in multiple sclerosis

Tankou, S. K., Regev, K., Healy, B. C., Cox, L. M., Tjon, E., Kivisakk, P., Vanande, I. P., Cook, S., Gandhi, R., Glanz, B., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517737390 · Cited by 156 · see citing works

Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens

Cree, B., Spencer, C. M., Varrin‐Doyer, M., Baranzini, S. E., & Zamvil, S. S. (2016) · Annals of Neurology · doi:10.1002/ana.24718 · Cited by 156 · see citing works

Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis

Riccio, P., & Rossano, R. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0581-4 · Cited by 156 · see citing works

The multiple sclerosis gut microbiota: A systematic review

Mirza, A., Forbes, J. D., Zhu, F., Bernstein, C. N., Domselaar, G. V., Graham, M., Waubant, E. L., & Tremlett, H. L. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101427 · Cited by 152 · see citing works

The Role of Gut Microbiota and Gut–Brain Interplay in Selected Diseases of the Central Nervous System

Doroszkiewicz, J., Groblewska, M., & Mroczko, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810028 · Cited by 160 · see citing works

Implications of Gut Microbiota in Neurodegenerative Diseases

Zhang, H., Chen, Y., Wang, Z., Xie, G., Liu, M., Yuan, B., Chai, H., Wang, W., & Cheng, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.785644 · Cited by 157 · see citing works

Urban-associated diseases: Candidate diseases, environmental risk factors, and a path forward

Flies, E. J., Mavoa, S., Zosky, G. R., Mantzioris, E., Williams, C. R., Eri, R. D., Brook, B. W., & Buettel, J. C. (2019) · Environment International · doi:10.1016/j.envint.2019.105187 · Cited by 154 · see citing works

Alterations of host-gut microbiome interactions in multiple sclerosis

Cantoni, C., Lin, Q., Dorsett, Y., Ghezzi, L., Liu, Z., Pan, Y., Chen, K., Han, Y., Li, Z., Xiao, H., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2021.103798 · Cited by 149 · see citing works

Environmental factors in autoimmune diseases and their role in multiple sclerosis

Haase, S., Grohme, D. A., Erzler, M., Binsfeld, M., Haghikia, A., Müller, D. N., Linker, R. A., & Kleinewietfeld, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2311-1 · Cited by 152 · see citing works

Diet, gut microbiota and cognition

Proctor, C., Thiennimitr, P., Chattipakorn, N., & Chattipakorn, S. C. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-016-9917-8 · Cited by 144 · see citing works

A clinical update on the significance of the gut microbiota in systemic autoimmunity

Rosser, E. C., & Mauri, C. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.06.009 · Cited by 140 · see citing works

The Gut Microbiome and Multiple SclerosisPreprint

Ochoa‐Repáraz, J., Kirby, T. O., & Kasper, L. H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029017 · Cited by 139 · see citing works

Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial

Huang, C., Yi, P., Zhu, M., Zhou, W., Zhang, B., Yi, X., Long, H., Zhang, G., Wu, H., Tsokos, G. C., et al. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102844 · Cited by 137 · see citing works

The role of gut microbiota in T cell immunity and immune mediated disorders

Shim, J. A., Ryu, J. H., Jo, Y., & Hong, C. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79430 · Cited by 134 · see citing works

Mining microbes for mental health: determining the role of microbial metabolic pathways in human brain health and disease

Spichak, S., Bastiaanssen, T. F. S., Berding, K., Vlckova, K., Clarke, G., Dinan, T. G., & Cryan, J. F. (2021) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.044 · Cited by 127 · see citing works

Prevotella histicola, A Human Gut Commensal, Is as Potent as COPAXONE® in an Animal Model of Multiple Sclerosis

Shahi, S. K., Freedman, S. N., Murra, A. C., Zarei, K., Sompallae, R. R., Gibson-Corley, K. N., Karandikar, N. J., Murray, J. A., & Mangalam, A. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00462 · Cited by 125 · see citing works

The Gut-Brain Axis in Inflammatory Bowel Disease—Current and Future Perspectives

Günther, C., Rothhammer, V., Karow, M., Neurath, M., & Winner, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168870 · Cited by 123 · see citing works

Prevotella histicola Protects From Arthritis by Expansion of Allobaculum and Augmenting Butyrate Production in Humanized Mice

Balakrishnan, B., Luckey, D. H., Bodkhe, R., Chen, J., Marietta, E. V., Jeraldo, P., Murray, J. A., & Taneja, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.609644 · Cited by 125 · see citing works

Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention

Zhang, L., Qing, P., Yang, H., Wu, Y., Liu, Y., & Luo, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.686501 · Cited by 124 · see citing works

Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome

Bicknell, B. T., Liebert, A. D., Borody, T. J., Herkes, G., McLachlan, C. S., & Kiat, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119577 · Cited by 129 · see citing works

Short-chain fatty acids and gut microbiota in multiple sclerosis

Melbye, P., Olsson, A., Hansen, T. H., Søndergaard, H. B., & Oturai, A. B. (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.13045 · Cited by 121 · see citing works

The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)

König, R. S., Albrich, W. C., Kahlert, C. R., Bahr, L. S., Löber, U., Vernazza, P., Scheibenbogen, C., & Forslund, S. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.628741 · Cited by 123 · see citing works

Gut Microbiota: A Possible Role in the Pathogenesis of Multiple Sclerosis

Yamamura, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-28609-9_10

Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls

Chen, J., Chia, N., Kalari, K. R., Yao, J. Z., Novotna, M., Paz Soldan, M. M., Luckey, D. H., Marietta, E. V., Jeraldo, P. R., Chen, X., et al. (2016) · Scientific Reports · doi:10.1038/srep28484 · Cited by 933 · see citing works

[Multiple Sclerosis and Commensal Gut Flora].

Yamamura, T. (2016) · PubMed · doi:10.11477/mf.1416200450

Integrative Cross-Cohort Meta-Analysis Reveals a Conserved Dysbiotic Signature of Streptococcaceae and Lachnospiraceae in Multiple SclerosisPreprint

Arif, A. M., Garg, P., & Srivastava, P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.25.740724

Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course

Ventura, R. E., Iizumi, T., Battaglia, T., Liu, M., Perez-Perez, G. I., Herbert, J., & Blaser, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-52894-z · Cited by 104 · see citing works